Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Ascierto, Paolo Antonio, Ferrucci, Pier Francesco, Fisher, Rosalie, Del Vecchio, Michele, Atkinson, Victoria, Schmidt, Henrik, Schachter, Jacob, Queirolo, Paola, Long, Georgina V., Di Giacomo, Anna MaLangue:
english
Journal:
Nature Medicine
DOI:
10.1038/s41591-019-0448-9
Date:
June, 2019
Fichier:
PDF, 1.47 MB
english, 2019